Phenotype: increased lymphocyte cell number
Definition greater than normal number of the cells involved in adaptive immune reactions of the body in most inflammatory and autoimmune diseases, including B cells, T cells and natural killer cells
Synonyms
- increased immune cell number
- increased immune cell number
- lymphocytosis
- lymphocytosis
- increased lymphocyte count
Related
Synonyms
Synonyms
- Increased B cell count
- Increased B cell count
- Increased T cell count
- Increased T cell count
- Lymphocytosis
- increased B cell number
- increased KLRG1-positive NK cell number
- increased Ly6C-positive immature NK cell number
- increased Ly6C-positive mature NK cell number
- increased NK cell number
- increased T cell number
- increased T-helper cell number
- increased activated T cell number
- increased alpha-beta T cell number
- increased gamma-delta T cell number
- increased immature B cell number
- increased immature NK cell number
- increased large unstained cell number
- increased mature B cell number
- increased mature NK cell number
- increased memory T cell number
- increased memory-marker NK cell number
- increased pre-B cell number
- increased regulatory T cell number
- increased single-positive T cell number
- increased thymocyte number
- increased uterine NK cell number
Procedure
- Hematology (IMPC, v2)
- Immunophenotyping (IMPC, v1)
- Bone marrow immunophenotyping (MGP, v1)
- Buffy coat peripheral blood leukocyte immunophenotyping (MGP, v1)
- Ear epidermis immunophenotyping (MGP, v1)
- FACS (HRWL, v1)
- FACS (ICS, v1)
- FACs Analysis (ESLIM, v1)
- FACs Analysis (M-G-P, v1)
- Haematology (GMC) (GMC, v1)
- Immunophenotyping (ICS, v2)
- Immunophenotyping (TCPLA, v1)
- Immunophenotyping (UCDLA, v1)
- Immunophenotyping (HMGULA, v1)
- Immunophenotyping (RBRCLA, v1)
- Mesenteric Lymph Node Immunophenotyping (MGP, v1)
- Spleen Immunophenotyping (MGP, v1)
- Whole blood peripheral blood leukocyte immunophenotyping (SLM, v1)
- Whole blood peripheral blood leukocyte immunophenotyping (MGP, v1)
MP browserMP:0005013
Phenotype associations stats
5.88% of tested genes with null mutations on a B6N genetic background have a phenotype association to increased lymphocyte cell number (200/3403)
3.36% females (110/3270) 3.71% males (123/3313)
Select a parameter
Gene variants with increased lymphocyte cell number
Total number of significant genotype-phenotype associations: 604
Gene / Allele | Zygosity | Sex | Life Stage | Phenotype | Procedure | Parameter | Phenotyping Center | Source | P Value | Data |
---|---|---|---|---|---|---|---|---|
Adap1 Adap1^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased NK cell number | Spleen Immunophenotyping | Total NK cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Aicda Aicda^{tm1b(EUCOMM)Hmgu} |
HOM | postnatal | increased early germinal center B cell number | Mesenteric Lymph Node Immunophenotyping | Early germinal centre B cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Aicda Aicda^{tm1b(EUCOMM)Hmgu} |
HOM | postnatal | increased germinal center B cell number | Mesenteric Lymph Node Immunophenotyping | Germinal centre B cells - % of B2 cells | WTSI | 3i | 0.0 | ||
Aicda Aicda^{tm1b(EUCOMM)Hmgu} |
HOM | postnatal | decreased late germinal center B cell number | Mesenteric Lymph Node Immunophenotyping | Late germinal centre B cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Amz2 Amz2^{tm1e(KOMP)Wtsi} |
HOM | postnatal | increased mature B cell number | Whole blood peripheral blood leukocyte immunophenotyping | IgD+ mature B cell percentage | WTSI | 3i | 0.0 | ||
Arhgap17 Arhgap17^{tm1b(EUCOMM)Wtsi} |
HOM | postnatal | increased transitional stage T1 B cell number | Spleen Immunophenotyping | Transitional 1 B cells - % of B2 cells | WTSI | 3i | 0.0 | ||
Arhgap30 Arhgap30^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased effector memory CD4-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD44+ CD62L- alpha beta effector T cell percentage | WTSI | 3i | 0.0 | ||
Arhgap30 Arhgap30^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased effector memory CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ CD44+ CD62L- alpha beta effector T cell percentage | WTSI | 3i | 0.0 | ||
Arhgap30 Arhgap30^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased gamma-delta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Gamma delta T cell percentage | WTSI | 3i | 0.0 | ||
Arhgap30 Arhgap30^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased NK cell number | Whole blood peripheral blood leukocyte immunophenotyping | NK cell percentage | WTSI | 3i | 0.0 | ||
Arhgef1 Arhgef1^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased KLRG1-positive NK cell number | Mesenteric Lymph Node Immunophenotyping | KLRG1+ NK cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Arhgef1 Arhgef1^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Mesenteric Lymph Node Immunophenotyping | KLRG1+ Treg cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Arhgef1 Arhgef1^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased gamma-delta T cell number | Mesenteric Lymph Node Immunophenotyping | Total gd T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Arhgef1 Arhgef1^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased Ly6C-positive NK T cell number | Spleen Immunophenotyping | Ly6C+ NKT cells - % of NKT cells | WTSI | 3i | 0.0 | ||
Arhgef1 Arhgef1^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased mature NK cell number | Spleen Immunophenotyping | Mature NK cells - % of NK cellls | WTSI | 3i | 0.0 | ||
Arhgef1 Arhgef1^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased effector memory CD8-positive, alpha-beta T cell number | Spleen Immunophenotyping | Resting CD8+ T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Arhgef1 Arhgef1^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased CD4-positive, alpha beta T cell number | Spleen Immunophenotyping | Total CD4+ T cells - % of ab T cells | WTSI | 3i | 0.0 | ||
Arhgef1 Arhgef1^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased effector memory CD4-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD44+ CD62L- alpha beta effector T cell number | WTSI | 3i | 0.0 | ||
Arpc1b Arpc1b^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased memory-marker CD4-negative NK T cell number | Mesenteric Lymph Node Immunophenotyping | Effector CD4- NKT cells - % of CD4- NKT cells | WTSI | 3i | 0.0 | ||
Arpc1b Arpc1b^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Mesenteric Lymph Node Immunophenotyping | KLRG1+ Treg cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Arpc1b Arpc1b^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased plasma cell number | Mesenteric Lymph Node Immunophenotyping | Plasma cells - % of B2 cells | WTSI | 3i | 0.0 | ||
Arpc1b Arpc1b^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Spleen Immunophenotyping | Effector Treg cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Arpc1b Arpc1b^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased immature NK cell number | Spleen Immunophenotyping | Immature NK cells - % of NK cells | WTSI | 3i | 0.0 | ||
Arpc1b Arpc1b^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased memory-marker NK cell number | Spleen Immunophenotyping | Resting NK cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Arpc1b Arpc1b^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Spleen Immunophenotyping | Total Treg cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Arpc1b Arpc1b^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased effector memory CD4-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD44+ CD62L- alpha beta effector T cell percentage | WTSI | 3i | 0.0 | ||
Atp11a Atp11a^{tm1a(KOMP)Wtsi} |
HET | postnatal | increased effector memory CD4-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD44+ CD62L- alpha beta effector T cell number | WTSI | 3i | 0.0 | ||
Bach2 Bach2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased immature B cell number | Bone marrow immunophenotyping | Immature B cells (Hardy fraction E) - % of B220+ | WTSI | 3i | 0.0 | ||
Bach2 Bach2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased effector memory CD8-positive, alpha-beta T cell number | Mesenteric Lymph Node Immunophenotyping | Effector CD8+ T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Bach2 Bach2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased memory-marker NK cell number | Mesenteric Lymph Node Immunophenotyping | Effector NK cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Bach2 Bach2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Mesenteric Lymph Node Immunophenotyping | Effector Treg cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Bach2 Bach2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased KLRG1-positive NK cell number | Mesenteric Lymph Node Immunophenotyping | KLRG1+ NK cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Bach2 Bach2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Mesenteric Lymph Node Immunophenotyping | KLRG1+ Treg cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Bach2 Bach2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased KLRG1-positive gamma-delta T cell number | Mesenteric Lymph Node Immunophenotyping | KLRG1+ gd T cells - % of gd T cells | WTSI | 3i | 0.0 | ||
Bach2 Bach2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased NK cell number | Mesenteric Lymph Node Immunophenotyping | Total NK cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Bach2 Bach2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased memory-marker CD4-negative NK T cell number | Spleen Immunophenotyping | Effector CD4- NKT cells - % of CD4- NKT cells | WTSI | 3i | 0.0 | ||
Bach2 Bach2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased KLRG1-positive CD4-negative NK T cell number | Spleen Immunophenotyping | KLRG1+ CD4- NKT cells - % of CD4- NKT cells | WTSI | 3i | 0.0 | ||
Bach2 Bach2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased KLRG1+ CD8 alpha beta T cell number | Spleen Immunophenotyping | KLRG1+ CD8+ T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Bach2 Bach2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased effector memory CD4-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD44+ CD62L- alpha beta effector T cell percentage | WTSI | 3i | 0.0 | ||
Bach2 Bach2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased KLRG1+ CD4 alpha beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ KLRG1+ alpha beta T cell percentage | WTSI | 3i | 0.0 | ||
Brd2 Brd2^{em1(IMPC)Wtsi} |
HET | postnatal | increased CD4-positive, alpha beta T cell number | Spleen Immunophenotyping | Total CD4+ T cells - % of ab T cells | WTSI | 3i | 0.0 | ||
Camsap3 Camsap3^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased gamma-delta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Gamma delta T cell number | WTSI | 3i | 0.0 | ||
Cdh23 Cdh23^{tm2b(EUCOMM)Wtsi} |
HOM | postnatal | increased CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ alpha beta T cell percentage | WTSI | 3i | 0.0 | ||
Cdh23 Cdh23^{tm2b(EUCOMM)Wtsi} |
HOM | postnatal | increased NK cell number | Whole blood peripheral blood leukocyte immunophenotyping | NK cell percentage | WTSI | 3i | 0.0 | ||
Cgrrf1 Cgrrf1^{tm1b(KOMP)Wtsi} |
HOM | postnatal | increased CD5-positive gamma-delta T cell number | Mesenteric Lymph Node Immunophenotyping | CD5+ gd T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Cgrrf1 Cgrrf1^{tm1b(KOMP)Wtsi} |
HOM | postnatal | increased gamma-delta T cell number | Mesenteric Lymph Node Immunophenotyping | Total gd T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Clpp Clpp^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased mature B cell number | Bone marrow immunophenotyping | Mature B cells (Hardy fraction F) - % of CD45+ | WTSI | 3i | 0.0 | ||
Clpp Clpp^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased KLRG1-positive NK cell number | Mesenteric Lymph Node Immunophenotyping | KLRG1+ NK cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Clpp Clpp^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased NK cell number | Whole blood peripheral blood leukocyte immunophenotyping | NK cell number | WTSI | 3i | 0.0 | ||
Cog6 Cog6^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased CD5-positive gamma-delta T cell number | Mesenteric Lymph Node Immunophenotyping | CD5+ gd T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Cog6 Cog6^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased memory-marker gamma-delta T cell number | Mesenteric Lymph Node Immunophenotyping | Effector gd cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Cog6 Cog6^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased follicular B cell number | Mesenteric Lymph Node Immunophenotyping | Follicular B cells - % of B2 cells | WTSI | 3i | 0.0 | ||
Cog6 Cog6^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased KLRG1+ CD8 alpha beta T cell number | Mesenteric Lymph Node Immunophenotyping | KLRG1+ CD8+ T cells - % of CD8+ | WTSI | 3i | 0.0 | ||
Cog6 Cog6^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased KLRG1-positive NK cell number | Mesenteric Lymph Node Immunophenotyping | KLRG1+ NK cells - % of NK cells | WTSI | 3i | 0.0 | ||
Cog6 Cog6^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Mesenteric Lymph Node Immunophenotyping | KLRG1+ Treg cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Cog6 Cog6^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased B-2 B cell number | Mesenteric Lymph Node Immunophenotyping | Total B2 cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Cog6 Cog6^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased CD4-positive, alpha beta T cell number | Mesenteric Lymph Node Immunophenotyping | Total CD4+ T cells - % of ab T cells | WTSI | 3i | 0.0 | ||
Cog6 Cog6^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased gamma-delta T cell number | Mesenteric Lymph Node Immunophenotyping | Total gd T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Cog6 Cog6^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Spleen Immunophenotyping | Effector Treg cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Cog6 Cog6^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased plasma cell number | Spleen Immunophenotyping | Plasma cells - % of B2 cells | WTSI | 3i | 0.0 | ||
Cog6 Cog6^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased memory-marker NK cell number | Spleen Immunophenotyping | Resting NK cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Cog6 Cog6^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased CD4-negative NK T cell number | Spleen Immunophenotyping | Total CD4- NKT cells - % of NKT cells | WTSI | 3i | 0.0 | ||
Cog6 Cog6^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Spleen Immunophenotyping | Total Treg cells - % of CD4+ | WTSI | 3i | 0.0 | ||
Crls1 Crls1^{tm1a(EUCOMM)Wtsi} |
HET | postnatal | increased B cell number | Whole blood peripheral blood leukocyte immunophenotyping | B cell number | WTSI | 3i | 0.0 | ||
Crls1 Crls1^{tm1a(EUCOMM)Wtsi} |
HET | postnatal | increased mature B cell number | Whole blood peripheral blood leukocyte immunophenotyping | IgD+ mature B cell number | WTSI | 3i | 0.0 | ||
Cttnbp2 Cttnbp2^{tm1b(KOMP)Wtsi} |
HOM | postnatal | increased plasma cell number | Bone marrow immunophenotyping | Plasma cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Cttnbp2 Cttnbp2^{tm1b(KOMP)Wtsi} |
HOM | postnatal | increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Spleen Immunophenotyping | Effector Treg cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Cxcr2 Cxcr2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased memory-marker gamma-delta T cell number | Mesenteric Lymph Node Immunophenotyping | Effector gd cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Cxcr2 Cxcr2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased KLRG1+ CD8 alpha beta T cell number | Mesenteric Lymph Node Immunophenotyping | KLRG1+ CD8+ T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Cxcr2 Cxcr2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased memory-marker CD4-positive NK T cell number | Spleen Immunophenotyping | Effector CD4+ NKT cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Cxcr2 Cxcr2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased effector memory CD8-positive, alpha-beta T cell number | Spleen Immunophenotyping | Resting CD8+ T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Cxcr2 Cxcr2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased memory-marker NK cell number | Spleen Immunophenotyping | Resting NK cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Cxcr2 Cxcr2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased effector memory CD4-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD44+ CD62L- alpha beta effector T cell percentage | WTSI | 3i | 0.0 | ||
Cxcr2 Cxcr2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased gamma-delta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Gamma delta T cell percentage | WTSI | 3i | 0.0 | ||
D6Wsu163e D6Wsu163e^{tm1b(EUCOMM)Wtsi} |
HOM | postnatal | increased CD8-positive, alpha-beta T cell number | Mesenteric Lymph Node Immunophenotyping | Total CD8+ T cells - % of ab T cells | WTSI | 3i | 0.0 | ||
Dbn1 Dbn1^{tm1b(KOMP)Wtsi} |
HET | postnatal | increased CD8-positive, alpha-beta T cell number | Mesenteric Lymph Node Immunophenotyping | Total CD8+ T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Dlg4 Dlg4^{tm1e(EUCOMM)Wtsi} |
HOM | postnatal | increased B cell number | Whole blood peripheral blood leukocyte immunophenotyping | B cell percentage | WTSI | 3i | 0.0 | ||
Dph6 Dph6^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased CD5-positive gamma-delta T cell number | Mesenteric Lymph Node Immunophenotyping | CD5+ gd T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Dph6 Dph6^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased memory-marker gamma-delta T cell number | Mesenteric Lymph Node Immunophenotyping | Effector gd cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Dph6 Dph6^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Mesenteric Lymph Node Immunophenotyping | KLRG1+ Treg cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Dph6 Dph6^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased CD4-positive, alpha beta T cell number | Mesenteric Lymph Node Immunophenotyping | Total CD4+ T cells - % of ab T cells | WTSI | 3i | 0.0 | ||
Dph6 Dph6^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased gamma-delta T cell number | Mesenteric Lymph Node Immunophenotyping | Total gd T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Dph6 Dph6^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Spleen Immunophenotyping | Effector Treg cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Dph6 Dph6^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased marginal zone B cell number | Spleen Immunophenotyping | Marginal zone B cells - % of B2 cells | WTSI | 3i | 0.0 | ||
Dph6 Dph6^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased plasma cell number | Spleen Immunophenotyping | Plasma cells - % of B2 cells | WTSI | 3i | 0.0 | ||
Dph6 Dph6^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased memory-marker CD4-negative NK T cell number | Spleen Immunophenotyping | Resting CD4- NKT cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Dph6 Dph6^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Spleen Immunophenotyping | Total Treg cells - % of CD4+ | WTSI | 3i | 0.0 | ||
Dph6 Dph6^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased effector memory CD4-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD44+ CD62L- alpha beta effector T cell percentage | WTSI | 3i | 0.0 | ||
Duoxa2 Duoxa2^{tm1b(KOMP)Wtsi} |
HOM | postnatal | increased T-helper cell number | Mesenteric Lymph Node Immunophenotyping | CD4+ T helper cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Duoxa2 Duoxa2^{tm1b(KOMP)Wtsi} |
HOM | postnatal | increased effector memory CD8-positive, alpha-beta T cell number | Mesenteric Lymph Node Immunophenotyping | Resting CD8+ T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Duoxa2 Duoxa2^{tm1b(KOMP)Wtsi} |
HOM | postnatal | increased CD4-positive, alpha beta T cell number | Mesenteric Lymph Node Immunophenotyping | Total CD4+ T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Duoxa2 Duoxa2^{tm1b(KOMP)Wtsi} |
HOM | postnatal | increased T cell number | Mesenteric Lymph Node Immunophenotyping | Total T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Duoxa2 Duoxa2^{tm1b(KOMP)Wtsi} |
HOM | postnatal | increased alpha-beta T cell number | Mesenteric Lymph Node Immunophenotyping | Total ab T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Duoxa2 Duoxa2^{tm1b(KOMP)Wtsi} |
HOM | postnatal | increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Spleen Immunophenotyping | Total Treg cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Etv3 Etv3^{em1(IMPC)Wtsi} |
HOM | postnatal | increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD25+ alpha beta regulatory T cell percentage | WTSI | 3i | 0.0 | ||
Fam160a1 Fam160a1^{tm1b(EUCOMM)Wtsi} |
HET | postnatal | increased KLRG1-positive NK cell number | Spleen Immunophenotyping | KLRG1+ NK cells - % of NK cells | WTSI | 3i | 0.0 | ||
Fbxw26 Fbxw26^{tm1b(KOMP)Wtsi} |
HOM | postnatal | increased KLRG1-positive NK cell number | Spleen Immunophenotyping | KLRG1+ NK cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Fbxw26 Fbxw26^{tm1b(KOMP)Wtsi} |
HOM | postnatal | increased NK cell number | Spleen Immunophenotyping | Total NK cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Galnt18 Galnt18^{tm1b(KOMP)Wtsi} |
HOM | postnatal | increased NK cell number | Mesenteric Lymph Node Immunophenotyping | Total NK cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Gimap6 Gimap6^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased memory-marker CD4-negative NK T cell number | Spleen Immunophenotyping | Resting CD4- NKT cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Gmds Gmds^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased CD4-positive, alpha beta T cell number | Mesenteric Lymph Node Immunophenotyping | Total CD4+ T cells - % of ab T cells | WTSI | 3i | 0.0 | ||
Gmds Gmds^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased gamma-delta T cell number | Mesenteric Lymph Node Immunophenotyping | Total gd T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Gmds Gmds^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased immature NK cell number | Spleen Immunophenotyping | Immature NK cells - % of NK cells | WTSI | 3i | 0.0 | ||
Gmds Gmds^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased Ly6C-positive NK T cell number | Spleen Immunophenotyping | Ly6C+ NKT cells - % of lymphocytes | WTSI | 3i | 0.0 | ||
Gmds Gmds^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased memory-marker NK cell number | Spleen Immunophenotyping | Resting NK cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Gmds Gmds^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Spleen Immunophenotyping | Resting Treg cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Gmds Gmds^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased CD4-negative NK T cell number | Spleen Immunophenotyping | Total CD4- NKT cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Gmds Gmds^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased CD8-positive, alpha-beta T cell number | Spleen Immunophenotyping | Total CD8+ T cells - % of ab T cells | WTSI | 3i | 0.0 | ||
Gmds Gmds^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased NK T cell number | Whole blood peripheral blood leukocyte immunophenotyping | NKT cell percentage | WTSI | 3i | 0.0 | ||
Hbs1l Hbs1l^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased CD5-positive gamma-delta T cell number | Spleen Immunophenotyping | CD5+ gd T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Hbs1l Hbs1l^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased effector memory CD8-positive, alpha-beta T cell number | Spleen Immunophenotyping | Effector CD8+ T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Hbs1l Hbs1l^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Spleen Immunophenotyping | Effector Treg cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Hbs1l Hbs1l^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Spleen Immunophenotyping | Total Treg cells - % of CD4+ | WTSI | 3i | 0.0 | ||
Hbs1l Hbs1l^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Alpha beta T cell number | WTSI | 3i | 0.0 | ||
Hbs1l Hbs1l^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased effector memory CD4-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD44+ CD62L- alpha beta effector T cell percentage | WTSI | 3i | 0.0 | ||
Hbs1l Hbs1l^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ alpha beta T cell number | WTSI | 3i | 0.0 | ||
Hbs1l Hbs1l^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Total T cell number | WTSI | 3i | 0.0 | ||
Il27 Il27^{tm1b(EUCOMM)Wtsi} |
HOM | postnatal | increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Mesenteric Lymph Node Immunophenotyping | KLRG1+ Treg cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Irgm1 Irgm1^{em1(IMPC)Wtsi} |
HOM | postnatal | increased KLRG1-positive NK cell number | Whole blood peripheral blood leukocyte immunophenotyping | KLRG1+ mature NK cell percentage | WTSI | 3i | 0.0 | ||
L3mbtl2 L3mbtl2^{tm2a(EUCOMM)Wtsi} |
HET | postnatal | increased KLRG1-positive NK cell number | Whole blood peripheral blood leukocyte immunophenotyping | KLRG1+ mature NK cell number | WTSI | 3i | 0.0 | ||
Nbeal1 Nbeal1^{tm2b(EUCOMM)Hmgu} |
HOM | postnatal | increased gamma-delta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Gamma delta T cell percentage | WTSI | 3i | 0.0 | ||
Ncf2 Ncf2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased KLRG1-positive NK cell number | Whole blood peripheral blood leukocyte immunophenotyping | KLRG1+ mature NK cell percentage | WTSI | 3i | 0.0 | ||
Nr0b1 Nr0b1^{em2(IMPC)Wtsi} |
HEM | postnatal | increased T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Total T cell percentage | WTSI | 3i | 0.0 | ||
Nrbp1 Nrbp1^{tm3b(EUCOMM)Wtsi} |
HET | postnatal | increased CD8-positive, alpha-beta T cell number | Mesenteric Lymph Node Immunophenotyping | Total CD8+ T cells - % of ab T cells | WTSI | 3i | 0.0 | ||
Osbpl3 Osbpl3^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased KLRG1-positive NK cell number | Whole blood peripheral blood leukocyte immunophenotyping | KLRG1+ mature NK cell number | WTSI | 3i | 0.0 | ||
Pclaf Pclaf^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Mesenteric Lymph Node Immunophenotyping | Resting Treg cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Pclaf Pclaf^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased mature NK cell number | Spleen Immunophenotyping | Mature NK cells - % of NK cellls | WTSI | 3i | 0.0 | ||
Pepd Pepd^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased memory-marker NK cell number | Mesenteric Lymph Node Immunophenotyping | Effector NK cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Pepd Pepd^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased memory-marker CD4-negative NK T cell number | Mesenteric Lymph Node Immunophenotyping | Resting CD4- NKT cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Pepd Pepd^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased effector memory CD8-positive, alpha-beta T cell number | Mesenteric Lymph Node Immunophenotyping | Resting CD8+ T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Pepd Pepd^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Spleen Immunophenotyping | Effector Treg cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Pepd Pepd^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased CD4-positive, alpha beta T cell number | Spleen Immunophenotyping | Total CD4+ T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Pepd Pepd^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased effector memory CD4-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD44+ CD62L- alpha beta effector T cell number | WTSI | 3i | 0.0 | ||
Prkab1 Prkab1^{tm1b(KOMP)Wtsi} |
HOM | postnatal | increased memory-marker CD4-negative NK T cell number | Spleen Immunophenotyping | Effector CD4- NKT cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Prkab1 Prkab1^{tm1b(KOMP)Wtsi} |
HOM | postnatal | increased memory-marker gamma-delta T cell number | Spleen Immunophenotyping | Effector gd T cells - % of gd T cells | WTSI | 3i | 0.0 | ||
Rwdd1 Rwdd1^{tm1b(KOMP)Wtsi} |
HOM | postnatal | increased memory-marker gamma-delta T cell number | Spleen Immunophenotyping | Resting gd T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Rwdd1 Rwdd1^{tm1b(KOMP)Wtsi} |
HOM | postnatal | increased CD4-positive, alpha beta T cell number | Spleen Immunophenotyping | Total CD4+ T cells - % of ab T cells | WTSI | 3i | 0.0 | ||
Setd5 Setd5^{tm1a(EUCOMM)Wtsi} |
HET | postnatal | increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD25+ alpha beta regulatory T cell percentage | WTSI | 3i | 0.0 | ||
Sgsm1 Sgsm1^{tm1b(EUCOMM)Wtsi} |
HOM | postnatal | increased CD8-positive, alpha-beta T cell number | Spleen Immunophenotyping | Total CD8+ T cells - % of ab T cells | WTSI | 3i | 0.0 | ||
Sik3 Sik3^{tm1a(EUCOMM)Hmgu} |
HOM | postnatal | increased memory-marker NK cell number | Mesenteric Lymph Node Immunophenotyping | Effector NK cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Sik3 Sik3^{tm1a(EUCOMM)Hmgu} |
HOM | postnatal | increased memory-marker gamma-delta T cell number | Mesenteric Lymph Node Immunophenotyping | Effector gd T cells - % of gd T cells | WTSI | 3i | 0.0 | ||
Sik3 Sik3^{tm1a(EUCOMM)Hmgu} |
HOM | postnatal | increased KLRG1-positive CD4-negative NK T cell number | Mesenteric Lymph Node Immunophenotyping | KLRG1+ CD4- NKT cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Sik3 Sik3^{tm1a(EUCOMM)Hmgu} |
HOM | postnatal | increased KLRG1+ CD8 alpha beta T cell number | Mesenteric Lymph Node Immunophenotyping | KLRG1+ CD8+ T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Sik3 Sik3^{tm1a(EUCOMM)Hmgu} |
HOM | postnatal | increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Mesenteric Lymph Node Immunophenotyping | KLRG1+ Treg cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Sik3 Sik3^{tm1a(EUCOMM)Hmgu} |
HOM | postnatal | increased CD8-positive, alpha-beta T cell number | Mesenteric Lymph Node Immunophenotyping | Total CD8+ T cells - % of ab T cells | WTSI | 3i | 0.0 | ||
Sik3 Sik3^{tm1a(EUCOMM)Hmgu} |
HOM | postnatal | increased NK cell number | Mesenteric Lymph Node Immunophenotyping | Total NK cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Sik3 Sik3^{tm1a(EUCOMM)Hmgu} |
HOM | postnatal | increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Mesenteric Lymph Node Immunophenotyping | Total Treg cells - % of CD4+ | WTSI | 3i | 0.0 | ||
Sik3 Sik3^{tm1a(EUCOMM)Hmgu} |
HOM | postnatal | increased follicular B cell number | Spleen Immunophenotyping | Follicular B cells - % of B2 cells | WTSI | 3i | 0.0 | ||
Sik3 Sik3^{tm1a(EUCOMM)Hmgu} |
HOM | postnatal | increased Ly6C-positive NK T cell number | Spleen Immunophenotyping | Ly6C+ NKT cells - % of NKT cells | WTSI | 3i | 0.0 | ||
Sik3 Sik3^{tm1a(EUCOMM)Hmgu} |
HOM | postnatal | increased CD4-negative NK T cell number | Spleen Immunophenotyping | Total CD4- NKT cells - % of NKT cells | WTSI | 3i | 0.0 | ||
Spink14 Spink14^{tm1e(KOMP)Wtsi} |
HOM | postnatal | increased memory-marker NK cell number | Spleen Immunophenotyping | Resting NK cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Tmem127 Tmem127^{tm1(KOMP)Wtsi} |
HOM | postnatal | increased memory-marker NK cell number | Mesenteric Lymph Node Immunophenotyping | Resting NK cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Tmem127 Tmem127^{tm1(KOMP)Wtsi} |
HOM | postnatal | increased CD8-positive, alpha-beta T cell number | Mesenteric Lymph Node Immunophenotyping | Total CD8+ T cells - % of ab T cells | WTSI | 3i | 0.0 | ||
Tmem127 Tmem127^{tm1(KOMP)Wtsi} |
HOM | postnatal | increased alpha-beta T cell number | Mesenteric Lymph Node Immunophenotyping | Total ab T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Tmem127 Tmem127^{tm1(KOMP)Wtsi} |
HOM | postnatal | increased CD4-positive, alpha beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ alpha beta T cell percentage | WTSI | 3i | 0.0 | ||
Tmem127 Tmem127^{tm1(KOMP)Wtsi} |
HOM | postnatal | increased T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Total T cell percentage | WTSI | 3i | 0.0 | ||
Usp15 Usp15^{tm1b(EUCOMM)Wtsi} |
HOM | postnatal | increased KLRG1-positive NK cell number | Whole blood peripheral blood leukocyte immunophenotyping | KLRG1+ mature NK cell number | WTSI | 3i | 0.0 | ||
Usp15 Usp15^{tm1b(EUCOMM)Wtsi} |
HOM | postnatal | increased NK cell number | Whole blood peripheral blood leukocyte immunophenotyping | NK cell percentage | WTSI | 3i | 0.0 | ||
Xpnpep1 Xpnpep1^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased NK cell number | Whole blood peripheral blood leukocyte immunophenotyping | NK cell percentage | WTSI | 3i | 0.0 | ||
Ydjc Ydjc^{tm1(KOMP)Wtsi} |
HOM | postnatal | increased germinal center B cell number | Spleen Immunophenotyping | Germinal centre B cells - % of B2 cells | WTSI | 3i | 0.0 | ||
Spns2 Spns2^{tm1b(KOMP)Wtsi} |
HOM | postnatal | increased effector memory CD4-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD4+CD44+CD62L- percentage | WTSI | 3i | 2.55E-40 | ||
Sgms1 Sgms1^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased effector memory CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD8+CD44+CD62L- percentage | WTSI | 3i | 5.82E-24 | ||
Fbxo7 Fbxo7^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased effector memory CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD8+CD44+CD62L- percentage | WTSI | 3i | 1.93E-20 | ||
Pex3 Pex3^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | Treg cell CD25+ percentage | WTSI | 3i | 2.59E-18 | ||
Ppp5c Ppp5c^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD3+ percentage | WTSI | 3i | 3.04E-17 | ||
Elk4 Elk4^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased T cell number | FACs Analysis | CD25+ percentage of CD4+ T cells | HMGU | EuroPhenome | 1.06E-15 | ||
Fbxo7 Fbxo7^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased effector memory CD4-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD4+CD44+CD62L- percentage | WTSI | 3i | 4.74E-14 | ||
Crlf3 Crlf3^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD3+ percentage | WTSI | 3i | 4.69E-12 | ||
Dll1 Dll1^{tm1Gos} |
HET | postnatal | increased lymphocyte cell number | Haematology (GMC) | Absolute number of lymphocytes | HMGU | EuroPhenome | 7.75E-12 | ||
Hnrnpr Hnrnpr^{em1(IMPC)Marc} |
HOM | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte cell count | MARC | IMPC | 2.89E-11 | ||
Tcf7 Tcf7^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased B cell number | FACs Analysis | B cell CD19+ percentage | ICS | MGP | 3.25E-11 | ||
Synj1 Synj1^{tm1b(EUCOMM)Wtsi} |
HET | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte differential count | MRC Harwell | IMPC | 2.17E-10 | ||
4932414N04Rik 4932414N04Rik^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased mature B cell number | Buffy coat peripheral blood leukocyte immunophenotyping | Mature B cell IgD+ percentage | WTSI | 3i | 5.56E-10 | ||
Cpa1 Cpa1^{em1(IMPC)Marc} |
HOM | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte cell count | MARC | IMPC | 5.7E-10 | ||
Plcg2 Plcg2^{Ali14} |
HET | postnatal | increased T cell number | FACs Analysis | CD25+ percentage of CD4+ T cells | HMGU | EuroPhenome | 8.53E-10 | ||
Smc3 Smc3^{tm1a(EUCOMM)Wtsi} |
HET | postnatal | increased CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD8+ percentage | WTSI | 3i | 1.23E-9 | ||
Spns2 Spns2^{tm1b(KOMP)Wtsi} |
HOM | postnatal | increased effector memory CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD8+CD44+CD62L- percentage | WTSI | 3i | 1.24E-9 | ||
Hmgb1 Hmgb1^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased effector memory CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD8+CD44+CD62L- percentage | WTSI | 3i | 4.3E-9 | ||
Cenpj Cenpj^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD8+ percentage | WTSI | 3i | 5.07E-9 | ||
Lta Lta^{tm1.1(KOMP)Vlcg} |
HOM | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte cell count | UC Davis | IMPC | 5.68E-9 | ||
Arhgef4 Arhgef4^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased mature B cell number | FACs Analysis | Mature B cells IgD+ percentage | HMGU | EuroPhenome | 5.95E-9 | ||
Cenpj Cenpj^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD3+ percentage | WTSI | 3i | 7.11E-9 | ||
Mlec Mlec^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased effector memory CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD8+CD44+CD62L- percentage | WTSI | 3i | 1.03E-8 | ||
Nfkb1 Nfkb1^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased CD4-positive, alpha beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD4+ percentage | WTSI | 3i | 1.32E-8 | ||
Elk4 Elk4^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased B cell number | FACs Analysis | B cell CD19+ percentage | HMGU | EuroPhenome | 1.47E-8 | ||
Btk Btk^{tm1a(EUCOMM)Hmgu} |
HEM | postnatal | increased CD4-positive, alpha beta T cell number | FACs Analysis | T cell CD4+ percentage | ICS | MGP | 3.57E-8 | ||
Zswim1 Zswim1^{tm1b(KOMP)Mbp} |
HOM | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte cell count | MARC | IMPC | 9.94E-8 | ||
Dennd1b Dennd1b^{tm1a(EUCOMM)Hmgu} |
HOM | postnatal | increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD25+ alpha beta regulatory T cell percentage | WTSI | 3i | 1.0E-7 | ||
Upk1b Upk1b^{tm1b(KOMP)Wtsi} |
HOM | postnatal | increased CD4-positive, alpha beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ alpha beta T cell number | WTSI | 3i | 1.0E-7 | ||
B4galnt3 B4galnt3^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased CD8-positive, alpha-beta T cell number | FACs Analysis | T cell CD8+ percentage | ICS | MGP | 1.3E-7 | ||
2310022B05Rik 2310022B05Rik^{tm1a(EUCOMM)Hmgu} |
HOM | postnatal | increased B cell number | FACs Analysis | B cell CD19+ percentage | MRC Harwell | EuroPhenome | 1.36E-7 | ||
Lypd2 Lypd2^{em1(IMPC)Marc} |
HOM | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte differential count | MARC | IMPC | 1.37E-7 | ||
Arhgap25 Arhgap25^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased effector memory CD4-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD4+CD44+CD62L- percentage | WTSI | 3i | 1.56E-7 | ||
Cdc7 Cdc7^{tm1.1(KOMP)Vlcg} |
HET | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte differential count | TCP | IMPC | 1.68E-7 | ||
Pfkfb2 Pfkfb2^{tm1b(KOMP)Wtsi} |
HOM | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte differential count | MARC | IMPC | 1.8E-7 | ||
Hapln4 Hapln4^{em1(IMPC)Wtsi} |
HOM | postnatal | increased CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ alpha beta T cell percentage | WTSI | 3i | 2.0E-7 | ||
Hapln4 Hapln4^{em1(IMPC)Wtsi} |
HOM | postnatal | increased T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Total T cell percentage | WTSI | 3i | 2.0E-7 | ||
Cps1 Cps1^{em1(IMPC)H} |
HET | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte differential count | MRC Harwell | IMPC | 2.47E-7 | ||
Nr0b1 Nr0b1^{em2(IMPC)Wtsi} |
HEM | postnatal | increased CD4-positive, alpha beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ alpha beta T cell percentage | WTSI | 3i | 3.0E-7 | ||
Nr0b1 Nr0b1^{em2(IMPC)Wtsi} |
HEM | postnatal | increased CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ alpha beta T cell percentage | WTSI | 3i | 3.0E-7 | ||
Pex3 Pex3^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased CD4-positive, alpha beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD4+ percentage | WTSI | 3i | 3.91E-7 | ||
Nr0b1 Nr0b1^{em2(IMPC)Wtsi} |
HEM | postnatal | increased alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Alpha beta T cell percentage | WTSI | 3i | 4.0E-7 | ||
Usp47 Usp47^{tm1b(EUCOMM)Wtsi} |
HOM | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte differential count | MARC | IMPC | 4.12E-7 | ||
Bbof1 Bbof1^{em1(IMPC)Marc} |
HOM | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte differential count | MARC | IMPC | 4.19E-7 | ||
Gsdma3 Gsdma3^{tm1(KOMP)Vlcg} |
HOM | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte cell count | MARC | IMPC | 4.43E-7 | ||
Egfr Egfr^{tm1a(EUCOMM)Wtsi} |
HET | postnatal | increased effector memory CD4-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD4+CD44+CD62L- percentage | WTSI | 3i | 4.43E-7 | ||
Rhot2 Rhot2^{tm1(KOMP)Wtsi} |
HOM | postnatal | increased NK T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | NKT cell percentage | WTSI | 3i | 5.29E-7 | ||
Cdh23 Cdh23^{tm2b(EUCOMM)Wtsi} |
HOM | postnatal | increased alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Alpha beta T cell percentage | WTSI | 3i | 6.0E-7 | ||
Smc3 Smc3^{tm1a(EUCOMM)Wtsi} |
HET | postnatal | increased T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD3+ percentage | WTSI | 3i | 6.01E-7 | ||
Pex3 Pex3^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased mature B cell number | Buffy coat peripheral blood leukocyte immunophenotyping | Mature B cell IgD+ percentage | WTSI | 3i | 6.09E-7 | ||
Cdyl Cdyl^{em1(IMPC)Wtsi} |
HET | postnatal | increased NK cell number | Whole blood peripheral blood leukocyte immunophenotyping | NK cell percentage | WTSI | 3i | 7.0E-7 | ||
Exo5 Exo5^{em1(IMPC)Wtsi} |
HOM | postnatal | increased mature B cell number | Whole blood peripheral blood leukocyte immunophenotyping | IgD+ mature B cell percentage | WTSI | 3i | 7.0E-7 | ||
Pdzd8 Pdzd8^{tm1b(EUCOMM)Wtsi} |
HET | postnatal | increased large unstained cell number | Hematology | Large Unstained Cell (LUC) count | MRC Harwell | IMPC | 7.17E-7 | ||
Avp Avp^{tm1b(EUCOMM)Wtsi} |
HET | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte differential count | MRC Harwell | IMPC | 7.71E-7 | ||
Cdh23 Cdh23^{tm2b(EUCOMM)Wtsi} |
HOM | postnatal | increased T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Total T cell percentage | WTSI | 3i | 8.0E-7 | ||
Dph6 Dph6^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased effector memory CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ CD44+ CD62L- alpha beta effector T cell percentage | WTSI | 3i | 9.0E-7 | ||
Gmds Gmds^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased B cell number | Whole blood peripheral blood leukocyte immunophenotyping | B cell number | WTSI | 3i | 9.0E-7 | ||
Gmds Gmds^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased mature B cell number | Whole blood peripheral blood leukocyte immunophenotyping | IgD+ mature B cell number | WTSI | 3i | 9.0E-7 | ||
Hbs1l Hbs1l^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased CD4-positive, alpha beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ alpha beta T cell number | WTSI | 3i | 9.0E-7 | ||
Mpg Mpg^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased effector memory CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ CD44+ CD62L- alpha beta effector T cell percentage | WTSI | 3i | 9.0E-7 | ||
Ndufb8 Ndufb8^{tm1a(EUCOMM)Wtsi} |
HET | postnatal | increased CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ alpha beta T cell number | WTSI | 3i | 9.0E-7 | ||
Pepd Pepd^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ alpha beta T cell number | WTSI | 3i | 9.0E-7 | ||
Vamp3 Vamp3^{tm2b(EUCOMM)Wtsi} |
HOM | postnatal | increased B cell number | Whole blood peripheral blood leukocyte immunophenotyping | B cell number | WTSI | 3i | 9.0E-7 | ||
Vamp3 Vamp3^{tm2b(EUCOMM)Wtsi} |
HOM | postnatal | increased mature B cell number | Whole blood peripheral blood leukocyte immunophenotyping | IgD+ mature B cell number | WTSI | 3i | 9.0E-7 | ||
Gfi1b Gfi1b^{tm1b(EUCOMM)Hmgu} |
HET | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte differential count | MRC Harwell | IMPC | 9.23E-7 | ||
Irgm1 Irgm1^{em1(IMPC)Wtsi} |
HOM | postnatal | increased CD4-positive, alpha beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ alpha beta T cell percentage | WTSI | 3i | 1.0E-6 | ||
Pepd Pepd^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased KLRG1-positive NK cell number | Whole blood peripheral blood leukocyte immunophenotyping | KLRG1+ mature NK cell number | WTSI | 3i | 1.0E-6 | ||
Bap1 Bap1^{tm1a(EUCOMM)Hmgu} |
HET | postnatal | increased effector memory CD4-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD44+ CD62L- alpha beta effector T cell number | WTSI | 3i | 1.1E-6 | ||
Hbs1l Hbs1l^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased NK cell number | Whole blood peripheral blood leukocyte immunophenotyping | NK cell number | WTSI | 3i | 1.1E-6 | ||
Pepd Pepd^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased NK cell number | Whole blood peripheral blood leukocyte immunophenotyping | NK cell number | WTSI | 3i | 1.1E-6 | ||
Arhgap30 Arhgap30^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD25+ alpha beta regulatory T cell percentage | WTSI | 3i | 1.2E-6 | ||
Hbs1l Hbs1l^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased gamma-delta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Gamma delta T cell number | WTSI | 3i | 1.2E-6 | ||
Myl3 Myl3^{em1(IMPC)Wtsi} |
HET | postnatal | increased CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ alpha beta T cell percentage | WTSI | 3i | 1.2E-6 | ||
Tcerg1l Tcerg1l^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased NK cell number | Whole blood peripheral blood leukocyte immunophenotyping | NK cell percentage | WTSI | 3i | 1.2E-6 | ||
Gp6 Gp6^{tm2b(EUCOMM)Hmgu} |
HOM | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte cell count | ICS | IMPC | 1.37E-6 | ||
Tmem127 Tmem127^{tm1(KOMP)Wtsi} |
HOM | postnatal | increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD25+ alpha beta regulatory T cell number | WTSI | 3i | 1.4E-6 | ||
Hnrnph1 Hnrnph1^{tm1b(KOMP)Wtsi} |
HET | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte cell count | MARC | IMPC | 1.56E-6 | ||
Supt7l Supt7l^{tm1a(EUCOMM)Wtsi} |
HET | postnatal | increased effector memory CD4-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD4+CD44+CD62L- percentage | WTSI | 3i | 1.58E-6 | ||
Zc3h14 Zc3h14^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased gamma-delta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Gamma delta T cell percentage | WTSI | 3i | 1.6E-6 | ||
Trmt10a Trmt10a^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased NK T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | NKT cell percentage | WTSI | 3i | 1.62E-6 | ||
Spns2 Spns2^{tm1b(KOMP)Wtsi} |
HOM | postnatal | increased NK cell number | Buffy coat peripheral blood leukocyte immunophenotyping | NK cell percentage | WTSI | 3i | 1.66E-6 | ||
Tmod1 Tmod1^{tm1a(KOMP)Wtsi} |
HET | postnatal | increased effector memory CD4-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD4+CD44+CD62L- percentage | WTSI | 3i | 1.67E-6 | ||
Acp2 Acp2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased B cell number | FACs Analysis | B cell CD19+ percentage | MRC Harwell | EuroPhenome | 1.73E-6 | ||
Bhlhe40 Bhlhe40^{tm1b(KOMP)Wtsi} |
HOM | postnatal | increased B cell number | Whole blood peripheral blood leukocyte immunophenotyping | B cell percentage | WTSI | 3i | 1.8E-6 | ||
Myo7a Myo7a^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased NK T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | NKT cell percentage | WTSI | 3i | 1.86E-6 | ||
Cd28 Cd28^{tm1a(EUCOMM)Hmgu} |
HOM | postnatal | increased CD4-positive, alpha beta T cell number | FACs Analysis | T cell CD4+ percentage | MRC Harwell | EuroPhenome | 1.87E-6 | ||
Acer1 Acer1^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD25+ alpha beta regulatory T cell percentage | WTSI | 3i | 2.0E-6 | ||
Mast2 Mast2^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased mature B cell number | Whole blood peripheral blood leukocyte immunophenotyping | IgD+ mature B cell percentage | WTSI | 3i | 2.0E-6 | ||
Mir96 Mir96^{tm3.2(IMPC)Wtsi} |
HOM | postnatal | increased mature B cell number | Whole blood peripheral blood leukocyte immunophenotyping | IgD+ mature B cell percentage | WTSI | 3i | 2.0E-6 | ||
Tnfrsf1a Tnfrsf1a^{tm2b(EUCOMM)Wtsi} |
HOM | postnatal | increased large unstained cell number | Hematology | Large Unstained Cell (LUC) count | MRC Harwell | IMPC | 2.22E-6 | ||
Camsap3 Camsap3^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased B cell number | Whole blood peripheral blood leukocyte immunophenotyping | B cell number | WTSI | 3i | 2.3E-6 | ||
Camsap3 Camsap3^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased mature B cell number | Whole blood peripheral blood leukocyte immunophenotyping | IgD+ mature B cell number | WTSI | 3i | 2.3E-6 | ||
Ckb Ckb^{tm1.1(KOMP)Wtsi} |
HOM | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte differential count | UC Davis | IMPC | 2.35E-6 | ||
Spns2 Spns2^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased effector memory CD4-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD4+CD44+CD62L- percentage | WTSI | 3i | 2.53E-6 | ||
Tnfrsf1a Tnfrsf1a^{tm2b(EUCOMM)Wtsi} |
HOM | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte cell count | MRC Harwell | IMPC | 2.62E-6 | ||
Entpd1 Entpd1^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased T cell number | FACs Analysis | CD25+ percentage of CD4+ T cells | MRC Harwell | EuroPhenome | 3.17E-6 | ||
Pja1 PJA1 |
HEM | postnatal | increased B cell number | FACs Analysis | B cell CD19+ percentage | ICS | EuroPhenome | 3.59E-6 | ||
Nfkb1 Nfkb1^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD3+ percentage | WTSI | 3i | 3.6E-6 | ||
Ccdc106 Ccdc106^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased effector memory CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD8+CD44+CD62L- percentage | WTSI | 3i | 3.6E-6 | ||
Stambp Stambp^{tm1b(EUCOMM)Hmgu} |
HET | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte cell count | MRC Harwell | IMPC | 3.67E-6 | ||
Sytl1 Sytl1^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased effector memory CD4-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD4+CD44+CD62L- percentage | WTSI | 3i | 3.68E-6 | ||
Unk Unk^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased CD4-positive, alpha beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ alpha beta T cell percentage | WTSI | 3i | 3.7E-6 | ||
Kdm7a Kdm7a^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased B cell number | Buffy coat peripheral blood leukocyte immunophenotyping | B cell CD19+ percentage | WTSI | 3i | 3.79E-6 | ||
Cidec Cidec^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased B cell number | FACs Analysis | B cell CD19+ percentage | HMGU | EuroPhenome | 4.1E-6 | ||
Zkscan14 Zkscan14^{tm1a(EUCOMM)Wtsi} |
HET | postnatal | increased effector memory CD4-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD4+CD44+CD62L- percentage | WTSI | 3i | 5.29E-6 | ||
Reg3g Reg3g^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased effector memory CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD8+CD44+CD62L- percentage | WTSI | 3i | 5.95E-6 | ||
Hapln4 Hapln4^{em1(IMPC)Wtsi} |
HOM | postnatal | increased alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Alpha beta T cell percentage | WTSI | 3i | 6.0E-6 | ||
Tardbp Tardbp^{tm1b(EUCOMM)Wtsi} |
HET | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte differential count | MRC Harwell | IMPC | 6.09E-6 | ||
Smoc1 Smoc1^{tm1b(EUCOMM)Wtsi} |
HET | postnatal | increased large unstained cell number | Hematology | Large Unstained Cell (LUC) differential count | MRC Harwell | IMPC | 6.33E-6 | ||
Baz2b Baz2b^{em1(IMPC)Wtsi} |
HOM | postnatal | increased NK cell number | Whole blood peripheral blood leukocyte immunophenotyping | NK cell number | WTSI | 3i | 6.4E-6 | ||
Mysm1 Mysm1^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased T cell number | FACs Analysis | CD25+ percentage of CD4+ T cells | HMGU | MGP | 6.51E-6 | ||
Trmt10a Trmt10a^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD8+ percentage | WTSI | 3i | 6.83E-6 | ||
Kctd15 Kctd15^{tm1b(EUCOMM)Wtsi} |
HET | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte differential count | TCP | IMPC | 7.12E-6 | ||
Plekhm2 Plekhm2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD8+ percentage | WTSI | 3i | 7.21E-6 | ||
Setd1a Setd1a^{tm1a(EUCOMM)Wtsi} |
HET | postnatal | increased CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD8+ percentage | WTSI | 3i | 7.42E-6 | ||
Fbxo7 Fbxo7^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased NK cell number | Buffy coat peripheral blood leukocyte immunophenotyping | NK cell percentage | WTSI | 3i | 7.63E-6 | ||
Fntb Fntb^{tm1b(EUCOMM)Hmgu} |
HET | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte differential count | MARC | IMPC | 8.08E-6 | ||
Uhrf1 Uhrf1^{tm1a(EUCOMM)Wtsi} |
HET | postnatal | increased NK cell number | FACs Analysis | NK cell percentage | HMGU | MGP | 9.27E-6 | ||
Bbs5 Bbs5^{tm1b(EUCOMM)Wtsi} |
HOM | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte cell count | MRC Harwell | IMPC | 9.78E-6 | ||
Lamc3 Lamc3^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased NK T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | NKT cell percentage | WTSI | 3i | 1.04E-5 | ||
Stat1 Stat1^{tm2b(EUCOMM)Wtsi} |
HOM | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte cell count | ICS | IMPC | 1.14E-5 | ||
Pik3r2 Pik3r2^{tm1e(KOMP)Wtsi} |
HOM | postnatal | increased CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD8+ percentage | WTSI | 3i | 1.24E-5 | ||
Tmem189 Tmem189^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased B cell number | Buffy coat peripheral blood leukocyte immunophenotyping | B cell CD19+ percentage | WTSI | 3i | 1.28E-5 | ||
Lyst Lyst^{tm1b(EUCOMM)Wtsi} |
HOM | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte differential count | TCP | IMPC | 1.4E-5 | ||
Ppm1j Ppm1j^{tm1b(KOMP)Wtsi} |
HOM | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte differential count | MARC | IMPC | 1.41E-5 | ||
Cdh23 Cdh23^{tm2b(EUCOMM)Wtsi} |
HOM | postnatal | increased CD4-positive, alpha beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ alpha beta T cell percentage | WTSI | 3i | 1.49E-5 | ||
Id2 Id2^{tm2b(EUCOMM)Wtsi} |
HET | postnatal | increased CD4-positive, alpha beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ alpha beta T cell percentage | WTSI | 3i | 1.49E-5 | ||
Kdm4c Kdm4c^{tm1a(KOMP)Wtsi} |
HET | postnatal | increased B cell number | FACs Analysis | B cell CD19+ percentage | HMGU | EuroPhenome | 1.51E-5 | ||
Fbxo38 Fbxo38^{em2(IMPC)Marc} |
HOM | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte cell count | MARC | IMPC | 1.51E-5 | ||
Xpnpep1 Xpnpep1^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased effector memory CD4-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD44+ CD62L- alpha beta effector T cell percentage | WTSI | 3i | 1.57E-5 | ||
Vsig10 Vsig10^{em1(IMPC)Wtsi} |
HOM | postnatal | increased alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Alpha beta T cell percentage | WTSI | 3i | 1.59E-5 | ||
Cenpj Cenpj^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased NK cell number | Buffy coat peripheral blood leukocyte immunophenotyping | NK cell percentage | WTSI | 3i | 1.79E-5 | ||
Vsig10 Vsig10^{em1(IMPC)Wtsi} |
HOM | postnatal | increased T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Total T cell percentage | WTSI | 3i | 1.93E-5 | ||
Spns2 Spns2^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | Treg cell CD25+ percentage | WTSI | 3i | 1.99E-5 | ||
Lamc3 Lamc3^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased CD4-positive, alpha beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD4+ percentage | WTSI | 3i | 2.06E-5 | ||
Abhd17a Abhd17a^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased B cell number | Whole blood peripheral blood leukocyte immunophenotyping | B cell number | WTSI | 3i | 2.12E-5 | ||
Abhd17a Abhd17a^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased mature B cell number | Whole blood peripheral blood leukocyte immunophenotyping | IgD+ mature B cell number | WTSI | 3i | 2.12E-5 | ||
Arpc1b Arpc1b^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased effector memory CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ CD44+ CD62L- alpha beta effector T cell percentage | WTSI | 3i | 2.12E-5 | ||
Clpp Clpp^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased B cell number | Whole blood peripheral blood leukocyte immunophenotyping | B cell number | WTSI | 3i | 2.12E-5 | ||
Col4a2 Col4a2^{em1(IMPC)Wtsi} |
HET | postnatal | increased KLRG1-positive NK cell number | Whole blood peripheral blood leukocyte immunophenotyping | KLRG1+ mature NK cell percentage | WTSI | 3i | 2.12E-5 | ||
Enc1 Enc1^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased effector memory CD4-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD44+ CD62L- alpha beta effector T cell percentage | WTSI | 3i | 2.12E-5 | ||
Etv3 Etv3^{em1(IMPC)Wtsi} |
HOM | postnatal | increased effector memory CD4-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD44+ CD62L- alpha beta effector T cell percentage | WTSI | 3i | 2.12E-5 | ||
Hbs1l Hbs1l^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased B cell number | Whole blood peripheral blood leukocyte immunophenotyping | B cell number | WTSI | 3i | 2.12E-5 | ||
Hbs1l Hbs1l^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased mature B cell number | Whole blood peripheral blood leukocyte immunophenotyping | IgD+ mature B cell number | WTSI | 3i | 2.12E-5 | ||
Ndufb8 Ndufb8^{tm1a(EUCOMM)Wtsi} |
HET | postnatal | increased alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Alpha beta T cell number | WTSI | 3i | 2.12E-5 | ||
Ndufb8 Ndufb8^{tm1a(EUCOMM)Wtsi} |
HET | postnatal | increased T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Total T cell number | WTSI | 3i | 2.12E-5 | ||
Nek9 Nek9^{tm1a(EUCOMM)Wtsi} |
HET | postnatal | increased B cell number | Whole blood peripheral blood leukocyte immunophenotyping | B cell number | WTSI | 3i | 2.12E-5 | ||
Nek9 Nek9^{tm1a(EUCOMM)Wtsi} |
HET | postnatal | increased mature B cell number | Whole blood peripheral blood leukocyte immunophenotyping | IgD+ mature B cell number | WTSI | 3i | 2.12E-5 | ||
Tmem211 Tmem211^{tm1b(KOMP)Wtsi} |
HOM | postnatal | increased KLRG1-positive NK cell number | Whole blood peripheral blood leukocyte immunophenotyping | KLRG1+ mature NK cell percentage | WTSI | 3i | 2.12E-5 | ||
Etaa1 Etaa1^{em1(IMPC)Marc} |
HOM | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte cell count | MARC | IMPC | 2.18E-5 | ||
Cfap53 Cfap53^{em1(IMPC)Wtsi} |
HET | postnatal | increased KLRG1+ CD4 alpha beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ KLRG1+ alpha beta T cell percentage | WTSI | 3i | 2.26E-5 | ||
Ehmt1 Ehmt1^{tm1b(EUCOMM)Hmgu} |
HET | postnatal | increased gamma-delta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Gamma delta T cell percentage | WTSI | 3i | 2.26E-5 | ||
Fam160a1 Fam160a1^{tm1b(EUCOMM)Wtsi} |
HET | postnatal | increased NK T cell number | Whole blood peripheral blood leukocyte immunophenotyping | NKT cell number | WTSI | 3i | 2.31E-5 | ||
Ncapd2 Ncapd2^{em1(IMPC)Wtsi} |
HET | postnatal | increased alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Alpha beta T cell percentage | WTSI | 3i | 2.42E-5 | ||
Rnf10 Rnf10^{tm1b(KOMP)Wtsi} |
HOM | postnatal | increased KLRG1-positive NK cell number | Whole blood peripheral blood leukocyte immunophenotyping | KLRG1+ mature NK cell number | WTSI | 3i | 2.42E-5 | ||
Sh3bp4 Sh3bp4^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased KLRG1-positive NK cell number | Whole blood peripheral blood leukocyte immunophenotyping | KLRG1+ mature NK cell number | WTSI | 3i | 2.42E-5 | ||
Crls1 Crls1^{tm1a(EUCOMM)Wtsi} |
HET | postnatal | increased NK cell number | Whole blood peripheral blood leukocyte immunophenotyping | NK cell number | WTSI | 3i | 2.58E-5 | ||
Mkrn2 Mkrn2^{tm1b(KOMP)Wtsi} |
HOM | postnatal | increased effector memory CD4-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD44+ CD62L- alpha beta effector T cell number | WTSI | 3i | 2.58E-5 | ||
Rnf10 Rnf10^{tm1b(KOMP)Wtsi} |
HOM | postnatal | increased NK cell number | Whole blood peripheral blood leukocyte immunophenotyping | NK cell number | WTSI | 3i | 2.58E-5 | ||
Sh3bp4 Sh3bp4^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased NK cell number | Whole blood peripheral blood leukocyte immunophenotyping | NK cell number | WTSI | 3i | 2.58E-5 | ||
Duoxa2 Duoxa2^{tm1b(KOMP)Wtsi} |
HOM | postnatal | increased CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ alpha beta T cell percentage | WTSI | 3i | 2.75E-5 | ||
Tmem260 Tmem260^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased NK cell number | Whole blood peripheral blood leukocyte immunophenotyping | NK cell percentage | WTSI | 3i | 2.75E-5 | ||
Trim8 Trim8^{em1(IMPC)Wtsi} |
HOM | postnatal | increased NK cell number | Whole blood peripheral blood leukocyte immunophenotyping | NK cell percentage | WTSI | 3i | 2.75E-5 | ||
Tuft1 Tuft1^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased gamma-delta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Gamma delta T cell number | WTSI | 3i | 2.75E-5 | ||
Ube2d3 Ube2d3^{tm1b(EUCOMM)Hmgu} |
HET | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte differential count | MARC | IMPC | 2.81E-5 | ||
Aicda Aicda^{tm1b(EUCOMM)Hmgu} |
HOM | postnatal | increased B cell number | Whole blood peripheral blood leukocyte immunophenotyping | B cell number | WTSI | 3i | 3.11E-5 | ||
Ndufb8 Ndufb8^{tm1a(EUCOMM)Wtsi} |
HET | postnatal | increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD25+ alpha beta regulatory T cell number | WTSI | 3i | 3.11E-5 | ||
Pepd Pepd^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD25+ alpha beta regulatory T cell number | WTSI | 3i | 3.11E-5 | ||
Tbkbp1 Tbkbp1^{tm1b(EUCOMM)Wtsi} |
HOM | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte cell count | MRC Harwell | IMPC | 3.17E-5 | ||
Lamc3 Lamc3^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD3+ percentage | WTSI | 3i | 3.21E-5 | ||
Tmod1 Tmod1^{tm1a(KOMP)Wtsi} |
HET | postnatal | increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | Treg cell CD25+ percentage | WTSI | 3i | 3.46E-5 | ||
Josd1 Josd1^{em1(IMPC)Wtsi} |
HOM | postnatal | increased NK T cell number | Whole blood peripheral blood leukocyte immunophenotyping | NKT cell number | WTSI | 3i | 3.51E-5 | ||
Usp15 Usp15^{tm1b(EUCOMM)Wtsi} |
HOM | postnatal | increased NK T cell number | Whole blood peripheral blood leukocyte immunophenotyping | NKT cell number | WTSI | 3i | 3.51E-5 | ||
Zc3h14 Zc3h14^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased B cell number | Whole blood peripheral blood leukocyte immunophenotyping | B cell percentage | WTSI | 3i | 3.77E-5 | ||
Secisbp2 Secisbp2^{tm1a(EUCOMM)Wtsi} |
HET | postnatal | increased NK cell number | FACs Analysis | NK cell percentage | MRC Harwell | EuroPhenome | 4.04E-5 | ||
Esco1 Esco1^{tm1(KOMP)Wtsi} |
HOM | postnatal | increased CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD8+ percentage | WTSI | 3i | 4.13E-5 | ||
1810043G02Rik 1810043G02Rik^{tm1b(EUCOMM)Wtsi} |
HOM | postnatal | increased mature B cell number | Whole blood peripheral blood leukocyte immunophenotyping | IgD+ mature B cell percentage | WTSI | 3i | 4.18E-5 | ||
Dennd1b Dennd1b^{tm1a(EUCOMM)Hmgu} |
HOM | postnatal | increased mature B cell number | Whole blood peripheral blood leukocyte immunophenotyping | IgD+ mature B cell percentage | WTSI | 3i | 4.18E-5 | ||
Erlin2 Erlin2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD25+ alpha beta regulatory T cell percentage | WTSI | 3i | 4.18E-5 | ||
Nutm1 Nutm1^{tm1b(KOMP)Wtsi} |
HOM | postnatal | increased mature B cell number | Whole blood peripheral blood leukocyte immunophenotyping | IgD+ mature B cell percentage | WTSI | 3i | 4.18E-5 | ||
Pdlim1 Pdlim1^{em1(IMPC)Wtsi} |
HOM | postnatal | increased mature B cell number | Whole blood peripheral blood leukocyte immunophenotyping | IgD+ mature B cell percentage | WTSI | 3i | 4.18E-5 | ||
Psg20 Psg20^{em1(IMPC)Wtsi} |
HOM | postnatal | increased mature B cell number | Whole blood peripheral blood leukocyte immunophenotyping | IgD+ mature B cell percentage | WTSI | 3i | 4.18E-5 | ||
Sqor Sqor^{em1(IMPC)Wtsi} |
HET | postnatal | increased mature B cell number | Whole blood peripheral blood leukocyte immunophenotyping | IgD+ mature B cell percentage | WTSI | 3i | 4.18E-5 | ||
Tgm3 Tgm3^{em2(IMPC)Wtsi} |
HOM | postnatal | increased mature B cell number | Whole blood peripheral blood leukocyte immunophenotyping | IgD+ mature B cell percentage | WTSI | 3i | 4.18E-5 | ||
Hprt Hprt^{Tg(CMV-Cre)Brd} |
HOM | postnatal | increased effector memory CD4-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD4+CD44+CD62L- percentage | WTSI | 3i | 4.24E-5 | ||
Rhbdd1 Rhbdd1^{tm1.1Mfm} |
HOM | postnatal | increased T cell number | FACs Analysis | T cell CD3+ percentage | MRC Harwell | EuroPhenome | 4.24E-5 | ||
Naga Naga^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased effector memory CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD8+CD44+CD62L- percentage | WTSI | 3i | 4.57E-5 | ||
Txlna Txlna^{tm1b(EUCOMM)Hmgu} |
HET | postnatal | increased large unstained cell number | Hematology | Large Unstained Cell (LUC) count | MRC Harwell | IMPC | 4.71E-5 | ||
Slc5a7 Slc5a7^{tm1a(KOMP)Wtsi} |
HET | postnatal | increased T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD3+ percentage | WTSI | 3i | 4.71E-5 | ||
Myd88 Myd88^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased NK cell number | Buffy coat peripheral blood leukocyte immunophenotyping | NK cell percentage | WTSI | 3i | 5.25E-5 | ||
Wdr37 Wdr37^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | Treg cell CD25+ percentage | WTSI | 3i | 5.28E-5 | ||
C2cd4a C2cd4a^{em1(IMPC)H} |
HOM | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte differential count | MRC Harwell | IMPC | 5.34E-5 | ||
Trim25 Trim25^{tm2b(EUCOMM)Hmgu} |
HOM | postnatal | increased B cell number | Whole blood peripheral blood leukocyte immunophenotyping | B cell percentage | WTSI | 3i | 5.36E-5 | ||
Cog6 Cog6^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased effector memory CD4-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD44+ CD62L- alpha beta effector T cell percentage | WTSI | 3i | 5.41E-5 | ||
Cog6 Cog6^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased KLRG1+ CD4 alpha beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ KLRG1+ alpha beta T cell percentage | WTSI | 3i | 5.71E-5 | ||
Atl2 Atl2^{tm2b(EUCOMM)Hmgu} |
HET | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte differential count | MRC Harwell | IMPC | 5.74E-5 | ||
Rspo1 Rspo1^{tm2b(KOMP)Wtsi} |
HOM | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte cell count | ICS | IMPC | 5.74E-5 | ||
Trf Trf^{em1(IMPC)Rbrc} |
HET | postnatal | increased large unstained cell number | Hematology | Large Unstained Cell (LUC) count | RBRC | IMPC | 5.77E-5 | ||
Trmt10a Trmt10a^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD3+ percentage | WTSI | 3i | 5.94E-5 | ||
Rhbdf2 Rhbdf2^{not yet available} |
HOM | postnatal | increased B cell number | FACs Analysis | B cell CD19+ percentage | MRC Harwell | EuroPhenome | 6.11E-5 | ||
Itch Itch^{tm1b(EUCOMM)Hmgu} |
HOM | postnatal | increased large unstained cell number | Hematology | Large Unstained Cell (LUC) differential count | MRC Harwell | IMPC | 6.14E-5 | ||
Abca4 Abca4^{tm1a(EUCOMM)Wtsi} |
HET | postnatal | increased NK cell number | Buffy coat peripheral blood leukocyte immunophenotyping | NK cell percentage | WTSI | 3i | 6.15E-5 | ||
Pex3 Pex3^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased effector memory CD4-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD4+CD44+CD62L- percentage | WTSI | 3i | 6.2E-5 | ||
Cog6 Cog6^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased B cell number | Whole blood peripheral blood leukocyte immunophenotyping | B cell percentage | WTSI | 3i | 6.35E-5 | ||
Camsap3 Camsap3^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD25+ alpha beta regulatory T cell number | WTSI | 3i | 6.45E-5 | ||
Dusp3 Dusp3^{tm1b(KOMP)Wtsi} |
HOM | postnatal | increased effector memory CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD8+CD44+CD62L- percentage | WTSI | 3i | 6.57E-5 | ||
Usp11 Usp11^{tm1(KOMP)Wtsi} |
HEM | postnatal | increased CD4-positive, alpha beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD4+ percentage | WTSI | 3i | 6.64E-5 | ||
Cpgi11865 Cpgi11865^{tm1.1(NCC)WCS} |
HOM | postnatal | increased CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ alpha beta T cell percentage | WTSI | 3i | 6.68E-5 | ||
Sytl1 Sytl1^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased effector memory CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD8+CD44+CD62L- percentage | WTSI | 3i | 6.8E-5 | ||
Usp45 Usp45^{em1(IMPC)H} |
HOM | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte differential count | MRC Harwell | IMPC | 6.8E-5 | ||
Ufm1 Ufm1^{em1(IMPC)Marc} |
HET | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte cell count | MARC | IMPC | 7.14E-5 | ||
Cish Cish^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | Treg cell CD25+ percentage | WTSI | 3i | 7.63E-5 | ||
Prss53 Prss53^{em3(IMPC)Wtsi} |
HOM | postnatal | increased effector memory CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ CD44+ CD62L- alpha beta effector T cell percentage | WTSI | 3i | 7.67E-5 | ||
Sec1 Sec1^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD8+ percentage | WTSI | 3i | 8.21E-5 | ||
Pxylp1 Pxylp1^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD8+ percentage | WTSI | 3i | 8.21E-5 | ||
Kdm8 Kdm8^{tm1a(EUCOMM)Wtsi} |
HET | postnatal | increased B cell number | FACs Analysis | B cell CD19+ percentage | HMGU | EuroPhenome | 8.24E-5 | ||
Herc1 Herc1^{em3(IMPC)Wtsi} |
HOM | postnatal | increased B cell number | Whole blood peripheral blood leukocyte immunophenotyping | B cell number | WTSI | 3i | 8.27E-5 | ||
Nedd4 Nedd4^{tm2b(EUCOMM)Hmgu} |
HET | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte cell count | MRC Harwell | IMPC | 8.5E-5 | ||
Spns2 Spns2^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased NK cell number | Buffy coat peripheral blood leukocyte immunophenotyping | NK cell percentage | WTSI | 3i | 8.51E-5 | ||
Arhgap18 Arhgap18^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased effector memory CD4-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD4+CD44+CD62L- percentage | WTSI | 3i | 8.52E-5 | ||
Ppp5c Ppp5c^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD8+ percentage | WTSI | 3i | 9.49E-5 | ||
Arhgap25 Arhgap25^{tm1a(KOMP)Wtsi} |
HOM | postnatal | increased effector memory CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD8+CD44+CD62L- percentage | WTSI | 3i | 9.65E-5 | ||
Sec1 Sec1^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | increased T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD3+ percentage | WTSI | 3i | 9.72E-5 | ||
Trp53 Trp53^{tm1b(EUCOMM)Hmgu} |
HET | postnatal | increased lymphocyte cell number | Hematology | Lymphocyte differential count | MRC Harwell | IMPC | 9.87E-5 |